FDA
approval
· 2012-03-01
FDA Approved: ROZEREM — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
The FDA approved a supplemental application for ROZEREM (ramelteon) submitted by Takeda Pharmaceuticals America, Inc. The notice confirms the agency's approval …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ROZEREM (RAMELTEON)